A HIGHER AMOUNT OF LILOTOMAB PRE-DOSING INCREASES THE ACTIVITY-ADJUSTED AUC AND HAS A PROTECTIVE EFFECT AGAINST MYELOSUPPRESSION OF LUTETIUM (177LU)-LILOTOMAB SATETRAXETAN IN INDOLENT NHL PATIENTS

A. Kolstad; U. Madsbu; C. Stokke; J. Blakkisrud; A. Muftuler Londalen; J. Dahle; L. Baylor Curtis; A Ostengen; K. Brustad Melhus; S. Turner; M. Erlanson; T. Illidge; H. Holte

A HIGHER AMOUNT OF LILOTOMAB PRE-DOSING INCREASES THE ACTIVITY-ADJUSTED AUC AND HAS A PROTECTIVE EFFECT AGAINST MYELOSUPPRESSION OF LUTETIUM (177LU)-LILOTOMAB SATETRAXETAN IN INDOLENT NHL PATIENTS

A. Kolstad, U. Madsbu, C. Stokke, J. Blakkisrud, A. Muftuler Londalen, J. Dahle, L. Baylor Curtis, A Ostengen, K. Brustad Melhus, S. Turner, M. Erlanson, T. Illidge, H. Holte

Division of Cancer Sciences (L5)

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	468-469
Journal	Haematologica
Volume	102
Publication status	Published - 26 Jun 2017

Research Beacons, Institutes and Platforms

Manchester Cancer Research Centre

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Kolstad, A., Madsbu, U., Stokke, C., Blakkisrud, J., Londalen, A. M., Dahle, J., Curtis, L. B., Ostengen, A., Melhus, K. B., Turner, S., Erlanson, M., Illidge, T., & Holte, H. (2017). A HIGHER AMOUNT OF LILOTOMAB PRE-DOSING INCREASES THE ACTIVITY-ADJUSTED AUC AND HAS A PROTECTIVE EFFECT AGAINST MYELOSUPPRESSION OF LUTETIUM (177LU)-LILOTOMAB SATETRAXETAN IN INDOLENT NHL PATIENTS. Haematologica, 102, 468-469.

@article{e89b1d8ac3de40f488789ac9db1f1af9,

title = "A HIGHER AMOUNT OF LILOTOMAB PRE-DOSING INCREASES THE ACTIVITY-ADJUSTED AUC AND HAS A PROTECTIVE EFFECT AGAINST MYELOSUPPRESSION OF LUTETIUM (177LU)-LILOTOMAB SATETRAXETAN IN INDOLENT NHL PATIENTS",

author = "A. Kolstad and U. Madsbu and C. Stokke and J. Blakkisrud and Londalen, {A. Muftuler} and J. Dahle and Curtis, {L. Baylor} and A Ostengen and Melhus, {K. Brustad} and S. Turner and M. Erlanson and T. Illidge and H. Holte",

year = "2017",

month = jun,

day = "26",

language = "English",

volume = "102",

pages = "468--469",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

}

Kolstad, A, Madsbu, U, Stokke, C, Blakkisrud, J, Londalen, AM, Dahle, J, Curtis, LB, Ostengen, A, Melhus, KB, Turner, S, Erlanson, M, Illidge, T & Holte, H 2017, 'A HIGHER AMOUNT OF LILOTOMAB PRE-DOSING INCREASES THE ACTIVITY-ADJUSTED AUC AND HAS A PROTECTIVE EFFECT AGAINST MYELOSUPPRESSION OF LUTETIUM (177LU)-LILOTOMAB SATETRAXETAN IN INDOLENT NHL PATIENTS', Haematologica, vol. 102, pp. 468-469.

A HIGHER AMOUNT OF LILOTOMAB PRE-DOSING INCREASES THE ACTIVITY-ADJUSTED AUC AND HAS A PROTECTIVE EFFECT AGAINST MYELOSUPPRESSION OF LUTETIUM (177LU)-LILOTOMAB SATETRAXETAN IN INDOLENT NHL PATIENTS. / Kolstad, A.; Madsbu, U.; Stokke, C. et al.
In: Haematologica, Vol. 102, 26.06.2017, p. 468-469.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - A HIGHER AMOUNT OF LILOTOMAB PRE-DOSING INCREASES THE ACTIVITY-ADJUSTED AUC AND HAS A PROTECTIVE EFFECT AGAINST MYELOSUPPRESSION OF LUTETIUM (177LU)-LILOTOMAB SATETRAXETAN IN INDOLENT NHL PATIENTS

AU - Kolstad, A.

AU - Madsbu, U.

AU - Stokke, C.

AU - Blakkisrud, J.

AU - Londalen, A. Muftuler

AU - Dahle, J.

AU - Curtis, L. Baylor

AU - Ostengen, A

AU - Melhus, K. Brustad

AU - Turner, S.

AU - Erlanson, M.

AU - Illidge, T.

AU - Holte, H.

PY - 2017/6/26

Y1 - 2017/6/26

M3 - Meeting Abstract

SN - 0390-6078

VL - 102

SP - 468

EP - 469

JO - Haematologica

JF - Haematologica

ER -